James H. Stanker, Chief Financial Officer at Processa Pharmaceuticals, Inc. (PCSA), bought 6,000 shares at $4.00 ($24K) on 2020-10-01, disclosed to the SEC on 2020-10-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |